SCHEMBL4183360

SCHEMBL4183360

CCOC(=O)c1cnc(-c2ccc(F)c(F)c2)nc1NCCc1ccccn1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.48
MAPT P10636 3/20 0.48
KDM4E B2RXH2 2/20 0.48
LMNA P02545 2/20 0.45
MAPK1 P28482 2/20 0.45
TP53 P04637 2/20 0.45
MEN1 O00255 1/20 0.45
ALOX15 P16050 1/20 0.45
TSHR P16473 1/20 0.45
HTT P42858 1/20 0.45
PPP1CA P62136 1/20 0.45
KMT2A Q03164 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
HSD17B10 Q99714 1/20 0.45
FOS P01100 8/20 0.45
JUN P05412 8/20 0.45
NFKB1 P19838 8/20 0.45
NFKB2 Q00653 8/20 0.45
RELA Q04206 8/20 0.45
SMN1; SMN2 Q16637 4/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4183055 0.87 GBA1 (0.45) KDM4EMEN1HTTKMT2ANPSR1
SCHEMBL13743048 0.86 SMN1; SMN2 (0.48) ALDH1A1KDM4EMEN1HTTKMT2A
SCHEMBL13743477 0.84 NAMPT (0.45) KDM4EMAPK1ALOX15SMN1; SMN2NPC1
SCHEMBL13743051 0.84 NAMPT (0.46) ALDH1A1KDM4ELMNATP53HTT
SCHEMBL13743157 0.81 KDM4E (0.45) ALDH1A1KDM4ELMNAMAPK1TP53
SCHEMBL13743494 0.80 NAMPT (0.43) ALDH1A1KDM4ELMNAMAPK1TP53
SCHEMBL4181449 0.79 GBA1 (0.46) ALDH1A1KDM4ETSHRHTTKMT2A
SCHEMBL4176021 0.78 PDE10A (0.40) ALDH1A1KDM4EMEN1HTTKMT2A
SCHEMBL4176455 0.78 PGK1 (0.40) ALDH1A1MAPTKDM4EMEN1KMT2A
SCHEMBL13743133 0.77 KDM4E (0.46) ALDH1A1MAPTKDM4ELMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090198057-A1 Certain Chemical Entities, Compositions, and Methods CYTOKINETICS, INCORPORATED 2009-08-06 US disclosed
US-20090198057-A1 Certain Chemical Entities, Compositions, and Methods CYTOKINETICS, INCORPORATED 2009-08-06 US disclosed
US-20090198057-A1 Certain Chemical Entities, Compositions, and Methods CYTOKINETICS, INCORPORATED 2009-08-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090198057-A1 Certain Chemical Entities, Compositions, and Methods MYLK, MYH2, MYH10 ALDH1A1 1710/4885MAPT 530/4885KDM4E 3281/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.